Exicure, Inc., was founded on July 9, 2015. The company is focusing on exploring strategic alternatives after suspending its historical biotechnology R&D activities. It has acquired GPCR Therapeutics USA, which completed a Phase 2 clinical trial in blood cancer patients, and the company is managing related licensing and development obligations. 

Exicure, Inc. expects to issue 172,058 shares of common stock to GPCR Therapeutics, Inc. in settlement of a $1.0 million clinical milestone payment obligation. The milestone payment was triggered by the completion of the Phase 2 clinical trial of Burixafor (GPC-100). The shares will be issued at a deemed value of $5.81 per share, representing an aggregate deemed value of approximately $1.0 million.

Exicure

Exicure to Issue 172,058 Shares in $1.0 Mln Milestone Payment Settlement

Exicure to issue 172,058 shares of common stock to GPCR Therapeutics for a $1.0 million clinical milestone payment. The shares will be issued at a deemed value of $5.81 per share, with the completion expected during August 2026. This will help the company preserve cash and maintain financial flexibility.<img src="https://cdn.ainvest.com/aigc/hxcmp/images/compress-1cecd04826ed1001.png" alt="Exicure to Settle $1mln Clinical Milestone via Equity Issuance">

Exicure to Settle $1mln Clinical Milestone via Equity Issuance

Exicure, Inc. announced changes to its Board of Directors following a special meeting on June 24, 2026. Jung Kyu Ham resigned as a director, and Jin Young Go and Eui Seok Han were appointed as Class III directors, increasing the Board size to six. Eui Seok Han was determined to be an independent director under Nasdaq Listing Rules.Exicure, Inc. (NASDAQ: XCUR) announced changes to its Board of Directors following a special meeting on June 24, 2026. Jung Kyu Ham resigned from the Board, and in his place, Jin Young Go and Eui Seok Han were appointed as Class III directors. This appointment increased the Board size to six members. Eui Seok Han has been <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">determined to be an independent director</a> under Nasdaq Listing Rules.The changes reflect the company’s ongoing efforts to align its leadership structure with its strategic direction. Exicure has previously undergone several leadership transitions, including the <a href="https://www.sec.gov/Archives/edgar/data/1698530/000169853026000009/xcur-20260206.htm">resignation of Andy Yoo and Seung Ik Baik</a> from executive roles in February 2026, with no immediate successors appointed at that time. The recent appointments suggest a <a href="https://www.biopharmawatch.com/news/XCUR/exicure-inc-announces-appointment-of-new-ceo-and-cfo-and-changes-to-board-of-directors-chi-xcur-20230823">continued focus on board composition</a> and governance as the company explores strategic alternatives to maximize shareholder value.The company has not disclosed further details regarding the terms of the new directors or their specific roles on the Board. <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">Additional information is expected</a> to be filed with the U.S. Securities and Exchange Commission in accordance with regulatory requirements.

Exicure's Board of Directors Announces Changes and Appointments

Exicure has announced changes to its Board of Directors and committees following Jung Kyu Ham's resignation. Jin Young Go and Eui Seok Han have been appointed as Class III directors, and the Board has been increased from five to six members. The Audit Committee will consist of Yoon Tae Han, Dongho Lee, and Gyeong Seog Cheon, while the Compensation Committee will be composed of Eui Seok Han and Dongho Lee.Exicure, Inc. (NASDAQ: XCUR) has announced changes to its Board of Directors and related committees following recent leadership transitions. Jung Kyu Ham resigned from the Board, and in response, Jin Young Go and Eui Seok Han were appointed as Class III directors. This adjustment <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">increased the Board size</a> from five to six members. The Audit Committee has been restructured to include <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">Yoon Tae Han, Dongho Lee</a>, and Gyeong Seog Cheon. Meanwhile, the Compensation Committee now consists of <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">Eui Seok Han and Dongho Lee</a>. These changes reflect the company’s ongoing efforts to reconstitute its governance structure following <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">resignations and appointments in early 2026</a>.Previously, Exicure experienced significant leadership changes, including the resignation of Andy Yoo as CEO and Seung Ik Baik as CFO, with <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">no immediate successors named</a> at the time. The company has also seen <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">multiple board members resign</a>, including Andy Sassine, Timothy Walbert, and Bosun Hau. In response, <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">new directors were appointed</a>, Jung Kyu Ham, Jung Soo Kim, and Gyeung Seog Cheon.The Board also approved a one-time $20,000 cash payment to outgoing directors and to remaining directors, <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">Dongho Lee and Sangjin Yeo</a>. Additionally, Seung Ik Baik received a <a href="https://www.stocktitan.net/sec-filings/XCUR/8-k-exicure-inc-reports-material-event-0a644ce9fa41.html">$150,000 separation payment</a>.These developments highlight a period of transition for Exicure as it works to stabilize its leadership and governance structure. Investors are likely to monitor future announcements regarding permanent appointments for key executive roles and any strategic shifts under the new board composition.

Exicure Announces Board and Committee Changes, Appoints New Directors and Committee Members

Exicure Inc. received a notification from Nasdaq for failing to maintain a minimum stockholders' equity of $2.5 million. The company recently reported $2.1 million in stockholders' equity and inadequate market values of listed securities. Nasdaq has given Exicure 45 days to provide a plan to regain compliance. The company has implemented cost-reduction and restructuring initiatives and terminated non-essential consulting arrangements.Exicure Inc. (NASDAQ: EXIC) has been notified by Nasdaq that it has failed to meet the minimum stockholders' equity requirement of $2.5 million, a key listing standard under Nasdaq’s Rule 5810. As of its most recent financial report, the company reported stockholders' equity of $2.1 million, falling short of the threshold. Additionally, Exicure’s <a href="https://bvwd.ca.gov/first-dry/Exicure-Posts-Q1-2026-Loss-Flags-Going-Concern-and-Nasdaq-Compliance-Risks-29-2256">market value of listed securities</a> is below the required level, further contributing to the deficiency.Under Nasdaq’s procedures, the company has 45 calendar days to submit a plan to regain compliance with the listing standards. If the plan is accepted, Exicure may be granted an extension of up to 180 days to achieve compliance. However, if the company fails to submit a viable plan or regain compliance within the specified timeframe, Nasdaq may issue a Staff Delisting Determination, which could lead to the <a href="https://bvwd.ca.gov/first-dry/Exicure-Posts-Q1-2026-Loss-Flags-Going-Concern-and-Nasdaq-Compliance-Risks-29-2256">suspension and eventual delisting</a> of its securities.In response, Exicure has taken steps to address its financial position. The company has implemented cost-reduction measures and initiated restructuring efforts, including the termination of non-essential consulting agreements. These actions are intended to <a href="https://bvwd.ca.gov/first-dry/Exicure-Posts-Q1-2026-Loss-Flags-Going-Concern-and-Nasdaq-Compliance-Risks-29-2256">improve financial efficiency</a> and strengthen its balance sheet.Investors are advised to monitor Exicure’s progress in addressing the deficiency and its ability to meet Nasdaq’s requirements. The company is also required to make a public announcement regarding the notification and its compliance plan, if submitted, in accordance with <a href="https://bvwd.ca.gov/first-dry/Exicure-Posts-Q1-2026-Loss-Flags-Going-Concern-and-Nasdaq-Compliance-Risks-29-2256">Nasdaq’s disclosure obligations</a>.<img src="https://cdn.ainvest.com/aigc/hxcmp/images/compress-1ca84eab1d6d1002.png" alt="Exicure Receives Nasdaq Notice for Minimum Stockholders' Equity Violation">

XCUR News